Yolk Sac Tumor of the Ovary: A Retrospective Multicenter Study of 33 Japanese Women by Tohoku Gynecologic Cancer Unit (TGCU)
Open Access
- 1 January 2013
- journal article
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 230 (4) , 211-217
Abstract
Yolk sac tumor (YST) of the ovary is a rare germ cell tumor comprising about 1% of all ovarian malignancies. YST usually occurs as a rapidly growing unilateral tumor in young women. With the introduction of cisplatin, YST has been changed from a fatal tumor to a curable tumor. The standard treatment of YST consists of fertility-preserving surgery and 3 or 4 courses of adjuvant combination chemotherapy with bleomycin, etoposide, and cisplatin (BEP). However, the long-term prognosis of BEP-treated YST patients has not been well studied. We therefore conducted a retrospective multicenter study to investigate the prognostic factors of 33 YST patients, including 25 patients treated with BEP. The median age at initial treatment was 20 years (range 10-53). There were 15 patients (at stage I), one (stage II), 16 (stage III), and one (stage IV). Nominal and grouped numerical values were analyzed by the Kaplan-Meier method. All patients had unilateral tumor, with right-side predominance (23 patients; P = 0.02). Eighteen patients had pure YST, 13 had mixed germ cell tumor with YST component, and other 2 patients were not specified. Twenty-eight patients received fertility-preserving surgery. Twenty-seven patients had optimal surgery with less than 1 cm residual tumor diameter. Median number of chemotherapy courses was 5. Median follow-up period was 49 months. The cumulative 5-year survival rate was 87%. Univariate analysis revealed the following significant prognostic factors (P < 0.05): stage, tumor diameter, and residual tumor. Extensive debulking surgery to minimize residual tumor would improve the prognosis.Keywords
This publication has 10 references indexed in Scilit:
- Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institutionWorld Journal of Surgical Oncology, 2011
- Prognostic factors in women treated for ovarian yolk sac tumour: A retrospective analysis of 84 casesEuropean Journal of Cancer, 2011
- Yolk sac tumours of the ovary: Evaluation of clinicopathological features and prognostic factorsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumorGynecologic Oncology, 2008
- Yolk sac tumours of the ovary: an updateEuropean Journal of Surgical Oncology, 2006
- Prognostic factors of patients with yolk sac tumors of the ovaryAmerican Journal of Obstetrics and Gynecology, 2001
- Treatment of nondysgerminomatous ovarian germ cell tumorsCancer, 1999
- Management of Early Ovarian Cancer: Germ Cell and Sex Cord-Stromal TumorsGynecologic Oncology, 1994
- Retrospective review of 41 patients with endodermal sinus tumor of the ovaryInternational Journal of Gynecological Cancer, 1993
- Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 casesCancer, 1991